Pharma Focus Asia
KP - Choose our fully recyclable blister films

First-of-its-Kind Setmelanotide Discovered for Hypothalamic Obesity

Rhythm Pharmaceuticals, Inc discovers first-of-its-kind setmelanotide for the treatment of obesity.

Setmelanotide is not indicated for treating patients with suspected obesity due to POMC, PCSK1 or LEPR deficiency with POMC, PCSK1 or LEPR variants classified as benign or likely benign. It is also not indicated for obesity related with other genetic syndromes and general (polygenic) obesity.

Some of the side effects of caused with the treatment of Setmelanotide include skin pigmentation, depression, prolonged penile erection etc. For every six months monitoring of heart rate and blood pressure should be done as an essential standard clinical practice for patients treated with setmelanotide.

U.S. Food and Drug Administration (FDA) grants Setmelanotide, the breakthrough designation for the treatment of hypothalamic obesity.

Hypothalamic obesity is a rare cause of extreme obesity that damages the hypothalamic region of the brain including MC4R pathway. It also controls physiological functions such as hunger and weight regulation.

Patients with hypothalamic experience quick weight gain, reduction in energy expenditure and increase in hunger during first six to 12 months following tumor resection, and all these factors ultimately leading to severe obesity.

In U.S, currently there are approximately 5,000-10,000 patients suffering with hypothalamic obesity, giving rise to 500 new cases every year.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoBora Pharmaceuticals - Free WhitepaperThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® products5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 2023Reuters Events - Pharma Customer Engagement USA 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023
MasterControl - 6 Essential Features in an eQMS